Labs in Canada and abroad saw dose-dependent drops in HbA1c, better fasting glucose, and steady weight loss over weeks and months
[DOI] [PMC free article] [PubMed] [Google Scholar] 14.Petersen MC, Vatner DF, Shulman GI
[DOI] [PubMed] [Google Scholar] 44.Shaddinger BC, Young MA, Billiard J, Collins DA, Hussaini A, Nino A
Reduced Body Fat Storage: Increasing insulin secretion and reducing glucagon secretion, helps prevent excessive glucose availability for energy, which may decrease body fat storage
Concentrated solutions (10 mg/mL) require smaller injection volumes, which can be challenging to measure accurately with standard syringes
According to the ADA 2018 Guidelines [1], treatment for T2DM should start with monotherapy unless A1c is greater or equal than 9.0%, when dual therapy must be considered